Skip to content

Clinical trials

Completed Phase 2 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Completed Country / region: China Clear all

1,632 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20023
20036
20045
200516
200618
200728
200833
200936
201044
201151
201246
201346
201443
201556
201652
201785
201884
2019119
2020167
2021196
2022160
2023150
2024118
202551
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,632

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University78
Fudan University60
Jiangsu HengRui Medicine Co., Ltd.46
BeiGene31
Novartis Pharmaceuticals28
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.22
Akeso21
Peking Union Medical College Hospital19
Shanghai Jiao Tong University School of Medicine19
Chinese Academy of Medical Sciences18

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung88
Breast Neoplasms61
Carcinoma, Hepatocellular51
Stomach Neoplasms44
Nasopharyngeal Carcinoma39
Esophageal Squamous Cell Carcinoma35
Recurrence33
Diabetes Mellitus, Type 230
Hepatitis B, Chronic28
Colorectal Neoplasms25

Trials

Showing 1 to 25 of 1,632. Each trial links to its page on Pharma Observatory.

1,532 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.